392 related articles for article (PubMed ID: 17452303)
21. [A case of membranous glomerulonephritis in renal allograft].
Kanno T; Ito M; Kawase N; Taki Y; Yoshida H; Okuno H; Ogawa O
Hinyokika Kiyo; 2002 Jun; 48(6):379-82. PubMed ID: 12166242
[TBL] [Abstract][Full Text] [Related]
22. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
[TBL] [Abstract][Full Text] [Related]
23. Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids.
Quartuccio L; Soardo G; Romano G; Zaja F; Scott CA; De Marchi G; Fabris M; Ferraccioli G; De Vita S
Rheumatology (Oxford); 2006 Jul; 45(7):842-6. PubMed ID: 16418196
[TBL] [Abstract][Full Text] [Related]
24. An attempt to extend the donor criteria for successful living-related kidney transplantation from a donor with membranous nephropathy.
Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakamoto S; Yoshimura N
Transplant Proc; 2009; 41(1):446-9. PubMed ID: 19249577
[TBL] [Abstract][Full Text] [Related]
25. The pathology and clinical features of early recurrent membranous glomerulonephritis.
Rodriguez EF; Cosio FG; Nasr SH; Sethi S; Fidler ME; Stegall MD; Grande JP; Fervenza FC; Cornell LD
Am J Transplant; 2012 Apr; 12(4):1029-38. PubMed ID: 22233329
[TBL] [Abstract][Full Text] [Related]
26. De novo membranous glomerulonephritis in renal allografts in children.
Antignac C; Hinglais N; Gubler MC; Gagnadoux MF; Broyer M; Habib R
Clin Nephrol; 1988 Jul; 30(1):1-7. PubMed ID: 3061691
[TBL] [Abstract][Full Text] [Related]
27. A case of living-related renal transplant from the donor with membranous nephropathy.
Akioka K; Okamoto M; Ushigome H; Nobori S; Suzuki T; Sakai K; Sakamoto S; Urasaki K; Yanagisawa A; Fukatsu A; Yoshimura N
Clin Transplant; 2009 Aug; 23 Suppl 20():62-6. PubMed ID: 19594600
[TBL] [Abstract][Full Text] [Related]
28. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.
Thaunat O; Patey N; Gautreau C; Lechaton S; Fremeaux-Bacchi V; Dieu-Nosjean MC; Cassuto-Viguier E; Legendre C; Delahousse M; Lang P; Michel JB; Nicoletti A
Transplantation; 2008 Jun; 85(11):1648-53. PubMed ID: 18551073
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporine A in treatment of membranous lupus nephropathy.
Hu W; Liu Z; Shen S; Li S; Yao X; Chen H; Li L
Chin Med J (Engl); 2003 Dec; 116(12):1827-30. PubMed ID: 14687467
[TBL] [Abstract][Full Text] [Related]
30. Membranous glomerulonephritis may be associated with heavy marijuana abuse.
Bohatyrewicz M; Urasinska E; Rozanski J; Ciechanowski K
Transplant Proc; 2007 Dec; 39(10):3054-6. PubMed ID: 18089320
[TBL] [Abstract][Full Text] [Related]
31. Rituximab treatment of idiopathic membranous nephropathy.
Fervenza FC; Cosio FG; Erickson SB; Specks U; Herzenberg AM; Dillon JJ; Leung N; Cohen IM; Wochos DN; Bergstralh E; Hladunewich M; Cattran DC
Kidney Int; 2008 Jan; 73(1):117-25. PubMed ID: 17943078
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
Hristea D; Hadaya K; Marangon N; Buhler L; Villard J; Morel P; Martin PY
Transpl Int; 2007 Jan; 20(1):102-5. PubMed ID: 17181660
[TBL] [Abstract][Full Text] [Related]
33. Antiproteinuric drugs in patients with idiopathic membranous glomerulopathy.
Gansevoort RT; Heeg JE; Vriesendorp R; de Zeeuw D; de Jong PE
Nephrol Dial Transplant; 1992; 7 Suppl 1():91-6. PubMed ID: 1337189
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[TBL] [Abstract][Full Text] [Related]
35. Membranous glomerulopathy following kidney transplantation. Association with renal vein thrombosis in two of nine cases.
First MR; Mendoza N; Maryniak RK; Weiss MA
Transplantation; 1984 Dec; 38(6):603-7. PubMed ID: 6390820
[TBL] [Abstract][Full Text] [Related]
36. [Successful correction of post-transplantation nephrotic syndrome with mabtera].
Goriaĭnov VA; Kaabak MM; Babenko NN; Zokoev AK; Morozova MM; Shishlo LA
Ter Arkh; 2009; 81(12):34-6. PubMed ID: 20481046
[TBL] [Abstract][Full Text] [Related]
37. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy.
Hofstra JM; Deegens JK; Willems HL; Wetzels JF
Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774
[TBL] [Abstract][Full Text] [Related]
38. Titrating rituximab to circulating B cells to optimize lymphocytolytic therapy in idiopathic membranous nephropathy.
Cravedi P; Ruggenenti P; Sghirlanzoni MC; Remuzzi G
Clin J Am Soc Nephrol; 2007 Sep; 2(5):932-7. PubMed ID: 17702725
[TBL] [Abstract][Full Text] [Related]
39. Rituximab treatment of fibrillary glomerulonephritis.
Collins M; Navaneethan SD; Chung M; Sloand J; Goldman B; Appel G; Rovin BH
Am J Kidney Dis; 2008 Dec; 52(6):1158-62. PubMed ID: 18823685
[TBL] [Abstract][Full Text] [Related]
40. Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient.
Sakai K; Takasu J; Nihei H; Yonekura T; Aoki Y; Kawamura T; Mizuiri S; Aikawa A
Clin Transplant; 2010 Jul; 24 Suppl 22():60-5. PubMed ID: 20590697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
